Integrated approaches – Investing in efficient IBD treatment, enabling innovation in patient care delivery

Diabetes – Off-patent medicines can start a virtuous circle of high-quality treatments and better prevention

Delivering best access to care for people with chronic diseases

Respiratory diseases – Value Added Medicines help improve therapy adherence to deliver better health outcomes for patients

Cardiovascular diseases – More patients are being treated while the sustainability of the healthcare system remains ensured

Covid policy paper 2022 – Lessons learned

Scientific advice for continuous innovation in known molecules

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

Removing access barriers in Central and Eastern Europe – April 2022

Factsheet: The EU Bolar Exemption